The effects of multiple ingestion of Ten-cha on pharmacokinetics after single oral administration of simvastatin

Journal of the Showa Medical Association

Volumn 66, Issue 5, 2006, Pages 340-348

  Akaike, Akiko ^a   Uchida, Naoki ^a   Hirashima, Hayato ^a   Fukazawa, Ichiro ^a   Nishimura, Yuki ^a   Kurata, Norimitsu ^a   Kurosawa, Kenzo ^a   Matsuda, Kazuhiro ^a   Yano, Rei ^a   Sakuma, Dai ^a   Uchida, Eiji ^a   Yasuhara, Hajime ^a   Lee, Xiao Pen ^a   Sato, Keizo ^a  

^a SHOWA UNIVERSITY   (Japan)

Author keywords

CYP3A4; Food drug interaction; Pharmacokinetics; Simvastatin; Ten cha

Indexed keywords

EID: 33847075477     PISSN: 00374342     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Nishikawa M, Ariyoshi N, Kotani A, et al: Effects of continuous ingestion of tea or grape seed extracts on the pharmacokinetics of midazolam. Drug Metab Pharmacokinet 19 : 280-289, 2004.
2. Pal D and Mitra AK: MDR- and CYP3A4-mediated drug-herbal interactions. Life Sci 24 : 2131-2145, 2006.
3. Wang Z, Gorski J C, Hamman MA, et al: The effects of St John's wort (Hypericum perforatum) on human cytochrome P450 activity. Clin Pharmacol Ther 70 : 317-326, 2001.
4. De Castro WV, Mertens-Talcott S, Rubner A, et al: Variation of flavonoids and furanocoumarins in grapefruit juices: a potential source of variability in grapefruit juice-drug interaction studies. J Agric Food Chem 54 : 249-255, 2006.
5. Nishimura Y, Kurata N, Iwase M, et al: Inhibitory effects of herbal teas on cytochrome P450-mediated metabolic activities. J Pharmacol Sci 91(Suppl I ) : 279, 2003.
6. Lilja JJ, Kivisto KT, and Neuvonen PJ: Duration of effect of grapefruit juice on the pharmacokinetics of the CYP3A4 substrate simvastatin. Clin Pharmacol Ther 68 : 384-390, 2000.
7. Jemal M, Ouyang Z and Powell ML: Direct-injection LC-MS-MS method for high-throughput simultaneous quantitation of simvastatin and simvastatin acid in human plasma. J Pharm Biomed Anal 23 : 323-340, 2000.
8. Williams D and Feely J: Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors. Clin Pharmacokinet 41 : 343-370, 2002.
9. Veronese ML, Gillen LP, Burke JP, et al: Exposure-dependent inhibition of intestinal and hepatic CYP3A4 in vivo by grapefruit juice. J Clin Pharmacol 43 : 831-839, 2003.
10. Lilja JJ, Kivisto KT and Neuvonen PJ: Grapefruit Juice increases serum concentrations of atorvastatin and has no effect on pravastatin. Clin Pharmacol Ther 66 : 118-127, 1999.
11. Lilja JJ, Kivisto KT and Neuvonen PJ: Grapefruit juice-simvastatin interaction: effect on serum concentrations of simvastatin, simvastatin acid, and HMG-CoA reductase inhibitors. Clin Pharmacol Ther 64 : 477-483, 1998.
12. Lundahl J, Regardh CG, Edgar B, et al: Relationship between time of intake of grapefruit juice and its effect on pharmacokinetics and pharmacodynamics of felodipine in healthy subjects. Eur J Clin Pharmacol 49 : 61-67, 1995.
13. Bailey DG, Arnold JM, Strong HA, et al: Effect of grapefruit juice and naringin on nisoldipine pharmacokinetics. Clin Pharmacol Ther 54 : 589-594, 1993.
14. Tian R, Koyabu N, Takanaga H, et al: Effect of grapefruit juice and orange juice on the intestinal efflux of P-glycoprotein substrates. Pharm Res 19 : 802-809, 2002.
15. Honda Y, Ushigome F, Koyabu N, et al: Effects of grapefruit juice and orange juice components on P-glycoprotein- and MRP2-mediated drug efflux. Br J Pharmacol 143 : 856-864, 2004.
16. Spahn-Langguth H and Langguth P: Grapefruit juice enhances intestinal absorption of the P-glycoprotein substrate talinolol. Eur J Pharm Sci 12 : 361-367, 2001.
17. Sugimoto K, Ohmori M, Tsuruoka S, et al: Different effects of St John's wort on the pharmacokinetics of simvastatin and pravastatin. Clin Pharmacol Ther 70 : 518-524, 2001.
18. Palumbo G, Bacchi S, Palumbo P, et al: Grapefruit juice: potential drug interaction. Clin Ter 156 : 97-103, 2005.
19. Egashira K, Fukuda E, Onga T, et al: Pomelo-induced increase in the blood level of tacrolimus in a renal transplant patient. Transplantation 75 : 1057, 2003.
20. Grenier J, Fradette C, Morelli G, et al: Pomelo juice, but not cranberry juice, affects the pharmacokinetics of cyclosporine in humans. Clin Pharmacol Ther 79 : 255-262, 2006.
21. Lown KS, Mayo RR, Leichtman AB, et al: Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine. Clin Pharmacol Ther 62 : 248-260, 1997.
22. Hashida T, Masuda S, Uemoto S, et al: Pharmacokinatic and prognostic significance of intestinal MDR1 expression in recipients of living-donor liver transplantation. Clin Pharmacol Ther 69 : 308-316, 2001.
23. Lee JI, Chaves-Gnecco D, Amico JA, et al: Application of semisimultaneous midazolam administration for hepatic and intestinal Cytochrome P450 3A phenotyping. Clin Pharmacol Ther 72 : 718-728, 2002.
24. Ruschitzka F, Meier PJ, Turina M, et al: Acute heart transplant rejection due to Saint John's wort. Lancet 355 : 548-549, 2000.
25. Piscitelli SC, Burstein AH, Chaitt D, et al: Indinavir concentrations and St. John's wort. Lancet 355 : 547-548, 2000.
26. Bailey DG, Spence JD, Munoz C, et al: Interaction of citrus juices with felodipine and nifedipine. Lancet 337 : 268-269, 1991.
27. Xie HG and Kim RB: St John's wort-associated drug interactions: Short-term inhibition and long-term induction? Clin Pharmacol Ther 78 : 19-24, 2005.